UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035216
Receipt number R000039462
Scientific Title A study for laryngopharyngeal reflux after thoracic esophageal cancer surgery using multichannel intraluminal impedance and pH monitoring
Date of disclosure of the study information 2018/12/11
Last modified on 2019/10/28 19:47:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study for laryngopharyngeal reflux after thoracic esophageal cancer surgery using multichannel intraluminal impedance and pH monitoring

Acronym

A study for laryngopharyngeal reflux after thoracic esophageal cancer surgery

Scientific Title

A study for laryngopharyngeal reflux after thoracic esophageal cancer surgery using multichannel intraluminal impedance and pH monitoring

Scientific Title:Acronym

A study for laryngopharyngeal reflux after thoracic esophageal cancer surgery

Region

Japan


Condition

Condition

Thoracic esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

For thoracic esophageal cancer, a 24-hour multi-impedance-pH monitoring is performed before and after surgery in a case where surgery is performed, and changes in the throat head reflux before and after surgery are analyzed. We examine the relationship between LPR and subjective symptoms and endoscopic findings.

Basic objectives2

Others

Basic objectives -Others

Prospective observational study before and after surgery

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Result of 24-hour multi impedance-pH monitoring.And the relationship between questionnaire of symptoms, endoscopic examination findings and the results.

Key secondary outcomes

We analyze the correlation between MII / pH monitoring analysis results, respiratory function test, and blood test changes in serum Alb value and body weight before and after surgery, and study correlation.
We will also pick up cases of pneumonia that occurred in the first year after surgery and examine MII / pH monitoring results in those cases.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Patients who undergo esophageal resection for thoracic esophageal cancer are included. In addition to ordinary medical examination, examination for 24-hour multi-impedance / pH monitoring and questionnaire survey on reflux symptoms are added before surgery and 1 week after surgery.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Surgery (esophageal resection, reconstruction) is scheduled to be performed for thoracic esophageal cancer.
(2) Clinical stage cStage I, II, III in TNM classification (UICC-TNM 7th edition).
(3) Performance Status is 0 to 1 on the basis of ECOG.
(4) The age at registration is over 20 years old and under 85 years old.
(5) Participation in research Documents consent has been obtained from the patient himself.

Key exclusion criteria

(1) Have active infectious disease.
(2) Have heart disease accompanied by symptoms.
(3) Oral ingestion is impossible due to impaired passage of the esophagus.
(4) There is a history of psychiatric disorder or central nervous disorder that has not been controlled.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Kamei

Organization

Graduate School of Medicine, Tohoku University

Division name

Digestive surgery

Zip code

980-8574

Address

1-1 Seiryocho Aoba-ku, Sendai-shi, 980-8574

TEL

022-717-7214

Email

tkamei@surg.med.tohoku.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Kamei

Organization

Graduate School of Medicine, Tohoku University

Division name

Digestive surgery

Zip code

980-8574

Address

1-1 Seiryocho Aoba-ku, Sendai-shi, 980-8574

TEL

022-717-7214

Homepage URL


Email

tkamei@surg.med.tohoku.ac.jp


Sponsor or person

Institute

Graduate School of Medicine, Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Graduate School of Medicine, Tohoku University, Digestive surgery

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee, Tohoku University Graduate School of Medicine

Address

2-1 Seiryocho Aoba-ku, Sendai-shi

Tel

022-728-4105

Email

hosp-ken@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 12 Month 11 Day

Date of IRB

2019 Year 01 Month 23 Day

Anticipated trial start date

2019 Year 01 Month 23 Day

Last follow-up date

2024 Year 01 Month 23 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 12 Month 11 Day

Last modified on

2019 Year 10 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039462


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name